Murphy Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,635
Closed -$1.75M 244
2019
Q3
$1.75M Sell
17,635
-462
-3% -$43.9K 0.26% 88
2019
Q2
$1.67M Sell
18,097
-474
-3% -$45K 0.25% 93
2019
Q1
$1.75M Sell
18,571
-1,714
-8% -$150K 0.27% 91
2018
Q4
$1.3M Sell
20,285
-4,368
-18% -$322K 0.22% 106
2018
Q3
$2.21M Sell
24,653
-780
-3% -$68.9K 0.31% 83
2018
Q2
$2.02M Sell
25,433
-1,190
-4% -$98.8K 0.29% 88
2018
Q1
$2.38M Buy
26,623
+1,550
+6% +$149K 0.34% 77
2017
Q4
$2.62M Sell
25,073
-1,310
-5% -$148K 0.36% 75
2017
Q3
$3.85M Sell
26,383
-1,321
-5% -$180K 0.55% 54
2017
Q2
$3.6M Sell
27,704
-150
-0.5% -$18.4K 0.53% 56
2017
Q1
$3.46M Sell
27,854
-17
-0.1% -$2.03K 0.52% 55
2016
Q4
$3.23M Sell
27,871
-2,705
-9% -$301K 0.51% 54
2016
Q3
$3.2M Sell
30,576
-985
-3% -$107K 0.5% 59
2016
Q2
$3.11M Sell
31,561
-5,585
-15% -$578K 0.48% 58
2016
Q1
$3.72M Sell
37,146
-655
-2% -$67.4K 0.58% 49
2015
Q4
$4.53M Buy
37,801
+3,001
+9% +$347K 0.69% 46
2015
Q3
$3.76M Sell
34,800
-1,045
-3% -$130K 0.62% 46
2015
Q2
$4.15M Sell
35,845
-1,785
-5% -$204K 0.62% 47
2015
Q1
$4.34M Sell
37,630
-470
-1% -$56.2K 0.64% 43
2014
Q4
$4.26M Sell
38,100
-1,360
-3% -$143K 0.65% 45
2014
Q3
$3.74M Sell
39,460
-1,640
-4% -$148K 0.58% 48
2014
Q2
$3.53M Sell
41,100
-400
-1% -$30.4K 0.56% 51
2014
Q1
$2.9M Sell
41,500
-1,126
-3% -$89.2K 0.49% 60
2013
Q4
$3.6M Sell
42,626
-1,450
-3% -$115K 0.63% 47
2013
Q3
$3.4M Buy
44,076
+160
+0.4% +$11.2K 0.64% 42
2013
Q2
$2.57M Buy
+43,916
New +$2.64M 0.52% 58

Other funds holding CELG

Murphy Capital Management's CELG Position: Q4 2019 in Review

Murphy Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,635 shares — an estimated $1.75M sold.

Murphy Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.53M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Murphy Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Murphy Capital Management sold 17,635 Celgene Corp shares in Q4 2019, an estimated $1.75M.
  • Murphy Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Murphy Capital Management's Celgene Corp position peaked at $4.53M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Murphy Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.